Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Marksans Pharma Ltd - 524404 - Board Meeting Intimation for The Meeting Of The Board Of Directors Of The Company Will Be Held On Friday, 8Th February, 2019

 MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2019 ,inter alia, to consider and approve This is to inform you that the Meeting of the Board of Directors of the Company will be held on Friday, 8th February, 2019 at Mumbai, to consider and approve the Unaudited Financial Results of the Company (both Standalone and Consolidated) for the quarter ended 31st December, 2018. Please note that as per the Insider Trading Code of the Company, the Trading Window for dealing in Company's shares will remain closed for the Company's insiders from today i.e. 31st January, 2019 (Commencing from the time of above intimation to the Stock Exchanges) till Forty-Eight hours after the announcement of the Unaudited Financial Results on 8th February, 2019.
31-01-2019
Bigul

MARKSANS PHARMA LTD. - 524404 - Loss of Share Certificate / Issue of Duplicate Share Certificate

 Marksans Pharma Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.
29-01-2019
Bigul

Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Change in Directorate

 Sub: Change in Directors Dear Sir, This is to inform you that the Board of Directors of the Company at its meeting held today i.e. 24th January, 2019, has appointed Mr. Varddhman Vikramaditya Jain (DIN: 08338573) as a Director of the Company with effect from 24th January, 2019 to fill the casual vacancy caused by the resignation of Dr. Vinay Gopal Nayak. Further, the Board of Directors at its meeting held today i.e. 24th January, 2019, has also appointed Mr. Varddhman Vikramaditya Jain (DIN: 08338573) as a Whole-time Director of the Company in the Professional - Executive Director category to hold office for a period of Three (3) years with effect from 24th January, 2019.
24-01-2019
Bigul

Marksans Pharma Ltd - 524404 - Shareholding for the Period Ended December 31, 2018

 Marksans Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here
11-01-2019
Bigul

Marksans Pharma Ltd - 524404 - Statement Of Investor Complaints For The Quarter Ended December 2018

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Harshavardhan PanigrahiDesignation :- Company Secretary and Compliance Officer
10-01-2019
Bigul

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Change in Directorate

 Dear Sir, Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015 please be informed that Dr. Vinay Gopal Nayak (DIN: 02577389) has resigned as Director and Whole-time Director of the Company effective from 1st January, 2019.
31-12-2018
Bigul

MARKSANS PHARMA LTD. - 524404 - Loss of Share Certificate / Issue of Duplicate Share Certificate

 Marksans Pharma Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.
17-12-2018
Bigul

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Dear Sir, Please be informed that the Company is participating in an investor conference organized by IDFC Securities Limited
20-11-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Dear Sir, Enclosed herewith kindly find a News Release dated 13th November, 2018 of the Company.
13-11-2018
Bigul

Outcome of Board Meeting

 In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Unaudited Financial Results for the quarter ended 30th September, 2018 (both Standalone and Consolidated) approved by the Board of Directors at its meeting held today i.e. 13th November, 2018 along with Limited Review Reports thereon....
13-11-2018
Next Page
Close

Let's Open Free Demat Account